Building Blocks

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>PB-22 is a synthetic cannabinoid, which can be classified as a CB1 receptor agonist. It is one of the many cannabinoids that have been created in an attempt to circumvent drug laws by creating compounds that are similar to those found in cannabis but have different chemical structures. PB-22 has shown to increase locomotor activity and stimulate the cb1 receptor in mice. Magnetic resonance spectroscopy (MRS) and assays were used to determine the binding affinity of PB-22 for the CB1 receptor. The MRS data showed that PB-22 bound with high affinity to the CB1 receptor and had a lower affinity for CB2 receptors. This suggests that PB-22 may be more potent than other synthetic cannabinoids, such as JWH-018 and CP 55,940, which bind better with CB2 receptors than CB1 receptors.<br>PB-22 is an analog of JWH-073 and has been shown to have a stronger effect on locomotor activity than JWH</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Methyl 2,2-dichloro-1-methylcyclopropanecarboxylate is a cyclic compound with an effective rate of 11.6 s−1. It has been shown to be an effective catalyst for the electrochemical reduction of anthracene and other aromatic compounds in metallocomplexes. The catalytic activity of Methyl 2,2-dichloro-1-methylcyclopropanecarboxylate is dependent on the concentration and type of anion present in solution. In homogeneous systems, this compound is catalytically active for the electrochemical reduction of radical anions and polarographic oxidation of pyridine. This chemical also shows high electrochemical reductive activity towards palladium.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Amino-4-methyl-pyrimidine-5-carboxylic acid is a spleen cell immunogen that induces antibody production in animals. 2-Amino-4-methyl-pyrimidine-5-carboxylic acid is an immunogen that belongs to the class of pyrimidine carboxylic acids. It has been optimised for use as an animal vaccine by inoculating it into tissues and monitoring antibody production with an enzyme linked immunosorbent assay. This compound has also been used to monitor and screen for antibodies in liquid chromatography.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>1-Benzothiophene-6-carboxylic acid is a nicotinic acetylcholine receptor agonist that has been shown to have high oral bioavailability and efficacy in vivo. It binds to the α7 nicotinic acetylcholine receptor and activates the receptor, leading to increased neurotransmitter release. 1-Benzothiophene-6-carboxylic acid has been shown to be effective in vivo in models of neuropathic pain and Parkinson's disease. This drug also has a low affinity for other receptors, such as muscarinic acetylcholine receptors, which reduces the chance of adverse effects.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>5,5-Dicyclopropylimidazolidine-2,4-dione is an ammonium salt that has a strong antispasmodic effect. It is used to treat muscle spasms and other types of spasticity. 5,5-Dicyclopropylimidazolidine-2,4-dione also has an alkali metal (e.g., sodium) or alkali earth metal (e.g., magnesium) salt form that can be used for the treatment of cystitis, pyelonephritis, and other urinary tract infections. This compound is converted to the corresponding hydantoin derivative in vivo by hydrolysis of the ethoxide group. Hydantoins are related to the hydantoin class of nonsteroidal anti-inflammatory drugs (NSAIDs).</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>